Glimepiride

SourceSynthetic

Powder ColorWhite to Off-White

Forms AvailablePowder

Product TypeActive Pharmaceutical Ingredient (API)

OrganicUSP / BP / EP / IP Grade

PackagingHDPE Drums, Multi-layer Foil Bags, 25kg Standard Packaging

Container Capacity1kg, 5kg, 10kg, 25kg

Request a Quote Download Datasheet

Glimepiride is a high-potency, long-acting second-generation sulfonylurea oral hypoglycemic agent. It functions by binding to specific ATP-sensitive potassium channel receptors on the surface of pancreatic beta-cells, causing the channels to close. This induces cell depolarization and triggers a rapid influx of calcium ions, which stimulates the exocytosis and systemic release of endogenous insulin into the bloodstream to lower blood glucose levels, particularly after meals.

Type 2 Diabetes Management
Postprandial Glycemic Control
Beta-Cell Stimulation

Type 2 Diabetes Management
Postprandial Glycemic Control
Beta-Cell Stimulation
High Purity & Efficacy
USP / BP / EP / IP Grade Compliance
Stringent Quality Control & Batch Consistency

Pharmaceutical Formulations
Oral Solid Dosage (Tablets & Capsules)
Sterile Formulations / Injectables (where applicable)
Custom API Compounding

High Purity Active Ingredient Pharma Grade Standard Available for Commercial & R&D Batch